This federal contract IDV is a multiple-award Federal Supply Schedule (FSS) contract awarded by the Veterans Integrated Service Network 12 (VISN 12), a component of the Department of Veterans Affairs (VA), to Uswm LLC. The contract, which has a ceiling value of $25,812,235.30, falls under the Pharmaceuticals and Drugs schedule (FSS-61-IB) and allows for the procurement of various drugs, pharmaceuticals, and hematology-related products.
Uswm LLC is a for-profit limited liability company that specializes in the development and commercialization of pharmaceutical products, with a focus on treatments for opioid withdrawal and related conditions. The company has received significant federal grant funding to support its research and development initiatives, including a $5.8 million cooperative agreement from the National Institute on Drug Abuse (NIDA) to expand the label for lofexidine (Lucemyra) to include treatment of opioid withdrawal in adolescents and a grant-funded project to develop lofexidine as a first-line non-opioid treatment for Neonatal Opioid Withdrawal Syndrome (NOWS). In addition to its grant-funded research, Uswm LLC holds multiple Federal Supply Schedule contracts with the VA, including this IDV that runs through February 2026.
Generated 1/7/25, 11:33 AM